Welcome back to the IDEA Collider podcast. In this episode, host Rick Ritacco sits down with Kwame Ferreira, Founder of Synthetic Users, and Rebecca Gould, President, Strategic Consulting & Analytics Business Unit at SAI. Together, they explore how artificial intelligence and synthetic behavioral modeling are transforming pharmaceutical market research and insight generation.

Listen to the full episode here: https://ideacollider.simplecast.com/

For decades, market research operated under a strict constraint: you could choose two between speed, price, and quality, but never all three. 

Rebecca and Kwame discuss how Synthetic User technology breaks this triangle, allowing biopharma teams to generate high-quality qualitative insights rapidly and cost-effectively.

Kwame breaks down the architecture behind Synthetic Users – defining them as an abstraction of brain architecture that replicates human emotional responses, cognitive biases, and system 1 behaviors rather than striving for super intelligence. Rebecca shares real-world case studies in rare diseases, competitive simulation workshops, and creative concept testing where synthetic personas achieved over 90% parity with live human respondents.